Literature DB >> 12189621

Macrophage migration inhibitory factor in uveitis.

Satoshi Kotake1, Nobuyoshi Kitaichi, Shigeaki Ohno.   

Abstract

To summarize, we found that high levels of MIF were detected in the serum of uveitis patients with Behçet's disease, VKH disease, and sarcoidosis, as well as idiopathic iridocyclitis. In Behçet's disease and sarcoidosis, the MIF levels were higher in the active uveitis stage than in the inactive stage. Serum MIF increased after corticosteroid therapy in VKH disease. A high aqueous humor MIF concentration was detected at the onset of EAU. Finally, anti-MIF antibody suppressed EAU when administered in the early phase. MIF is thought to be an important cytokine in the pathogenesis of uveitis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12189621     DOI: 10.1097/00004397-200201000-00014

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN: 0020-8167


  11 in total

1.  Ocular immune privilege in the year 2010: ocular immune privilege and uveitis.

Authors:  Andrew W Taylor; Henry J Kaplan
Journal:  Ocul Immunol Inflamm       Date:  2010-12       Impact factor: 3.070

2.  The positive role of lumbar puncture in the diagnosis of Vogt-Koyanagi-Harada disease: lymphocyte subsets in the aqueous humor and cerebrospinal fluid.

Authors:  Nobuyoshi Kitaichi; Hiroko Matoba; Shigeaki Ohno
Journal:  Int Ophthalmol       Date:  2007-01-09       Impact factor: 2.031

Review 3.  Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype?

Authors:  Kenneth G-J Ooi; Grazyna Galatowicz; Virginia L Calder; Susan L Lightman
Journal:  Clin Med Res       Date:  2006-12

4.  Usefulness of quantifying serum KL-6 levels in the follow-up of uveitic patients with sarcoidosis.

Authors:  Nobuyoshi Kitaichi; Toshihide Ariga; Satoru Kase; Kauzhiko Yoshida; Kenichi Namba; Shigeaki Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-23       Impact factor: 3.117

5.  Elevation of surfactant protein D, a pulmonary disease biomarker, in the sera of uveitis patients with sarcoidosis.

Authors:  Nobuyoshi Kitaichi; Mizuki Kitamura; Kenichi Namba; Susumu Ishida; Shigeaki Ohno
Journal:  Jpn J Ophthalmol       Date:  2010-02-12       Impact factor: 2.447

6.  Increase of KL-6 in sera of uveitis patients with sarcoidosis.

Authors:  Nobuyoshi Kitaichi; Satoshi Kotake; Hitoshi Shibuya; Yukiho Yamada; Hitoshi Chiba; Kenichi Namba; Shigeaki Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-10-11       Impact factor: 3.117

7.  Modulating of ocular inflammation with macrophage migration inhibitory factor is associated with notch signalling in experimental autoimmune uveitis.

Authors:  H Yang; S Zheng; Y Mao; Z Chen; C Zheng; H Li; C Sumners; Q Li; P Yang; B Lei
Journal:  Clin Exp Immunol       Date:  2015-11-17       Impact factor: 4.330

8.  Macrophage migration inhibitory factor: a multifunctional cytokine in rheumatic diseases.

Authors:  Tsuyoshi Kasama; Kumiko Ohtsuka; Michihito Sato; Ryo Takahashi; Kuninobu Wakabayashi; Kazuo Kobayashi
Journal:  Arthritis       Date:  2010-12-26

9.  Dual effect of a polymorphism in the macrophage migration inhibitory factor gene is associated with new-onset Graves disease in a Taiwanese Chinese population.

Authors:  Yu-Huei Liu; Ching-Chu Chen; Chen-Ming Yang; Yi-Ju Chen; Fuu-Jen Tsai
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

Review 10.  Influence of molecular genetics in Vogt-Koyanagi-Harada disease.

Authors:  Joanne Yw Ng; Fiona Oj Luk; Timothy Yy Lai; Chi-Pui Pang
Journal:  J Ophthalmic Inflamm Infect       Date:  2014-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.